Insider Transactions in Q3 2022 at Cassava Sciences Inc (SAVA)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 08
2022
|
Sanford Robertson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,802
+0.27%
|
$64,446
$23.59 P/Share
|
|
Aug 23
2022
|
Richard Barry President & CEO |
BUY
Open market or private purchase
|
Indirect |
36,159
+16.26%
|
$831,657
$23.79 P/Share
|
|
Aug 23
2022
|
James William Kupiec Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+50.0%
|
$60,000
$24.44 P/Share
|
|
Aug 12
2022
|
Sanford Robertson Director |
BUY
Open market or private purchase
|
Direct |
100,000
+8.89%
|
$2,000,000
$20.69 P/Share
|
|
Aug 12
2022
|
Eric Schoen Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+11.21%
|
$47,500
$19.95 P/Share
|